<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03714347</url>
  </required_header>
  <id_info>
    <org_study_id>TÜTF-BAEK 2016/225</org_study_id>
    <secondary_id>TÜTF-BAEK</secondary_id>
    <nct_id>NCT03714347</nct_id>
  </id_info>
  <brief_title>The Effect of Cerebral Oxygenation on Postoperative Recovery in Intracranial Surgery</brief_title>
  <acronym>Oxygenation</acronym>
  <official_title>The Effect of Cerebral Oxygenation on Postoperative Recovery in Intracranial Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Trakya University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Trakya University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study was to investigate the effect of cerebral oxygenation on postoperative
      compilation in intracranial surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients undergoing intracranial surgery will be divided into two groups; group (Group
      Control n = 100) and cerebral oxygenation monitoring group (Group Oxygen). all hemodynamic
      parameters such as systolic blood pressure and diastolic blood pressure, oxygen saturation,
      Et CO2, SpO2;% and BIS during anesthesia during anesthesia will be recorded intraoperatively
      and 10 postoperatively in 5 min intervals. After extubation, Modified Aldrete Score, GKS
      (Glasgow Coma Scale), Ramsey Sedation Scale (RSS), nausea-vomiting and pain will be recorded
      in the recovery room. Pain assessment will be done with Visual Analog Scale (VAS). Patient
      satisfaction will be recorded. MMST (mini mental state test) and ASEM (antisaccadic eye
      movement test) tests will be performed preoperatively and postoperatively at 1st, 2nd and 3rd
      days.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 28, 2016</start_date>
  <completion_date type="Anticipated">January 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>cerebral oxygen monitoring data</measure>
    <time_frame>cerebral oxygen values reported will be measured at 10 min intervals (intraoperative) and It would be reported by the first postoperative 10 minute intervals up to 30 minutes</time_frame>
    <description>cerebral oxygen monitoring will measure peroperative</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Intracranial Neoplasm</condition>
  <arm_group>
    <arm_group_label>Group Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>routine monitoring will be applied to this group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group Oxygen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>cerebral oxygen monitoring is applied to this group</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>cerebral oxygen monitoring</intervention_name>
    <description>probes will be placed on eyebrows on forehead</description>
    <arm_group_label>Group Oxygen</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>routine monitoring</intervention_name>
    <description>We will use routine monitoring intervention such as hate rate, arterial pressure, BIS. cerebral oxygen monitoring will not be applied to this group</description>
    <arm_group_label>Group Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Intracranial surgery will be performed

          -  Age 25-75

          -  ASA in the I-II-III risk group

        Exclusion Criteria:

          -  Under GKS 15

          -  heart failure,

          -  renal insufficiency,

          -  liver failure,

          -  congenital neurological deficits
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Emre Deren, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Trakya University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sevtap Hekimoglu Sahin, Professor</last_name>
    <email>sevtaphekimoglu@mynet.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Beyhan Karamanlıoglu, professor</last_name>
    <email>beykar@mynet.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Trakya University</name>
      <address>
        <city>Edirne</city>
        <state>Centrum</state>
        <zip>22030</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sevtap Hekimoglu Sahin, Professor</last_name>
      <email>sevtaphekimoglu@mynet.com</email>
    </contact>
    <contact_backup>
      <last_name>Beyhan Karamanlıoglu, Professor</last_name>
      <email>beykar@mynet.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>October 18, 2018</study_first_submitted>
  <study_first_submitted_qc>October 19, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 22, 2018</study_first_posted>
  <last_update_submitted>October 19, 2018</last_update_submitted>
  <last_update_submitted_qc>October 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 22, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Trakya University</investigator_affiliation>
    <investigator_full_name>Sevtap Hekimoglu Sahin</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <keyword>cerebral oxygen monitoring</keyword>
  <keyword>intracranial surgery</keyword>
  <keyword>general anesthesia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

